Unlocking the potential of ion channel biologics

TetraGenetics’ breakthrough technology produces unprecedented levels of correctly folded and functional membrane-spanning proteins that enable the discovery of novel therapeutic antibodies.

Jun 10, 2019
0
0
Page of

TetraGenetics

TetraGenetics is focused on the discovery and development of first-in-class biologic medicines for autoimmune diseases, oncology and pain. The company has the leading drug discovery platform (TetraExpress™) for identifying antibodies targeting ion channels and other transmembrane proteins. TetraGenetics is actively building a proprietary drug pipeline and working collaboratively with major biotech companies for antibody drug discovery.

No comments yet.